| 1 |
Murayama A, Kamamoto S, Saito H, Tanimoto T, Ozaki A. The Trend in Industry Payments During the COVID-19 Pandemic Among Gastroenterologists and Hepatologists in the United States. Cureus 2022;14:e32711. [PMID: 36686074 DOI: 10.7759/cureus.32711] [Reference Citation Analysis]
|
| 2 |
Singh A, Hyman MJ, Modi PK. Evaluation of Industry Payments to US Advanced Practice Clinicians in 2021. JAMA Netw Open 2022;5:e2242869. [PMID: 36399340 DOI: 10.1001/jamanetworkopen.2022.42869] [Reference Citation Analysis]
|
| 3 |
Kamamoto S, Murayama A, Kusumi E, Yoshida M, Saito H, Sawano T, Yamashita E, Tanimoto T, Ozaki A. Evaluation of financial relationships between Japanese certified pediatric hematologist/oncologists and pharmaceutical companies: a cross-sectional analysis of personal payments from pharmaceutical companies between 2016 and 2019. Pediatr Blood Cancer 2022;69:e29891. [PMID: 35949170 DOI: 10.1002/pbc.29891] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 4 |
Baraldi JH, Picozzo SA, Arnold JC, Volarich K, Gionfriddo MR, Piper BJ. A cross-sectional examination of conflict-of-interest disclosures of physician-authors publishing in high-impact US medical journals. BMJ Open 2022;12:e057598. [PMID: 35410932 DOI: 10.1136/bmjopen-2021-057598] [Reference Citation Analysis]
|
| 5 |
Baraldi JH, Picozzo SA, Arnold JC, Volarich K, Gionfriddo MR, Piper BJ. A Cross-Sectional Examination of Conflict-of-Interest Disclosures of Physician-Authors Publishing in High-Impact US Medical Journals.. [DOI: 10.1101/2021.09.12.21263468] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 6 |
Moynihan R, Albarqouni L, Nangla C, Dunn AG, Lexchin J, Bero L. Financial ties between leaders of influential US professional medical associations and industry: cross sectional study. BMJ 2020;369:m1505. [PMID: 32461201 DOI: 10.1136/bmj.m1505] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 7 |
Saito H, Ozaki A, Sawano T, Shimada Y, Yamamoto K, Suzuki Y, Tanimoto T. Pharmaceutical Company Payments to the Professors of Orthopaedic Surgery Departments in Japan. J Bone Joint Surg Am 2020;102:e39. [PMID: 32379127 DOI: 10.2106/JBJS.19.01005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 8 |
Wani S, Vargo J, Wallace M. Managing conflicts of interest in clinical practice guidelines. Gastrointest Endosc 2020;91:274-5. [PMID: 32036937 DOI: 10.1016/j.gie.2019.11.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 9 |
Bansal R, Khan R, Scaffidi MA, Gimpaya N, Genis S, Bukhari A, Dhillon J, Dao K, Bonneau C, Grover SC. Undisclosed payments by pharmaceutical and medical device manufacturers to authors of endoscopy guidelines in the United States. Gastrointest Endosc 2020;91:266-73. [PMID: 31738925 DOI: 10.1016/j.gie.2019.11.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 10 |
Ozieranski P, Csanadi M, Rickard E, Tchilingirian J, Mulinari S. Analysis of Pharmaceutical Industry Payments to UK Health Care Organizations in 2015. JAMA Netw Open 2019;2:e196253. [PMID: 31225896 DOI: 10.1001/jamanetworkopen.2019.6253] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 11 |
Fudman D, Feuerstein JD. The Call for Greater Transparency in Conflicts of Interest. JAMA Netw Open 2018;1:e186342. [PMID: 30646322 DOI: 10.1001/jamanetworkopen.2018.6342] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
